PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARCT vs. AMPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ARCTAMPH
YTD Return-35.39%-21.47%
1Y Return6.32%-7.59%
3Y Return (Ann)-18.55%31.81%
Sharpe Ratio0.10-0.18
Sortino Ratio0.720.02
Omega Ratio1.091.00
Calmar Ratio0.09-0.17
Martin Ratio0.21-0.27
Ulcer Index36.28%26.80%
Daily Std Dev76.24%40.39%
Max Drawdown-90.09%-49.92%
Current Drawdown-83.53%-25.28%

Fundamentals


ARCTAMPH
Market Cap$551.77M$2.34B
EPS-$2.33$3.01
Total Revenue (TTM)$148.46M$721.15M
Gross Profit (TTM)$152.16M$374.85M
EBITDA (TTM)-$48.31M$256.15M

Correlation

-0.50.00.51.00.2

The correlation between ARCT and AMPH is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ARCT vs. AMPH - Performance Comparison

In the year-to-date period, ARCT achieves a -35.39% return, which is significantly lower than AMPH's -21.47% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%JuneJulyAugustSeptemberOctoberNovember
-29.08%
14.63%
ARCT
AMPH

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ARCT vs. AMPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcturus Therapeutics Holdings Inc. (ARCT) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARCT
Sharpe ratio
The chart of Sharpe ratio for ARCT, currently valued at 0.10, compared to the broader market-4.00-2.000.002.004.000.10
Sortino ratio
The chart of Sortino ratio for ARCT, currently valued at 0.72, compared to the broader market-4.00-2.000.002.004.006.000.72
Omega ratio
The chart of Omega ratio for ARCT, currently valued at 1.09, compared to the broader market0.501.001.502.001.09
Calmar ratio
The chart of Calmar ratio for ARCT, currently valued at 0.09, compared to the broader market0.002.004.006.000.09
Martin ratio
The chart of Martin ratio for ARCT, currently valued at 0.21, compared to the broader market0.0010.0020.0030.000.21
AMPH
Sharpe ratio
The chart of Sharpe ratio for AMPH, currently valued at -0.18, compared to the broader market-4.00-2.000.002.004.00-0.18
Sortino ratio
The chart of Sortino ratio for AMPH, currently valued at 0.02, compared to the broader market-4.00-2.000.002.004.006.000.02
Omega ratio
The chart of Omega ratio for AMPH, currently valued at 1.00, compared to the broader market0.501.001.502.001.00
Calmar ratio
The chart of Calmar ratio for AMPH, currently valued at -0.17, compared to the broader market0.002.004.006.00-0.17
Martin ratio
The chart of Martin ratio for AMPH, currently valued at -0.27, compared to the broader market0.0010.0020.0030.00-0.27

ARCT vs. AMPH - Sharpe Ratio Comparison

The current ARCT Sharpe Ratio is 0.10, which is higher than the AMPH Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of ARCT and AMPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
0.10
-0.18
ARCT
AMPH

Dividends

ARCT vs. AMPH - Dividend Comparison

Neither ARCT nor AMPH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ARCT vs. AMPH - Drawdown Comparison

The maximum ARCT drawdown since its inception was -90.09%, which is greater than AMPH's maximum drawdown of -49.92%. Use the drawdown chart below to compare losses from any high point for ARCT and AMPH. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%JuneJulyAugustSeptemberOctoberNovember
-83.53%
-25.28%
ARCT
AMPH

Volatility

ARCT vs. AMPH - Volatility Comparison

The current volatility for Arcturus Therapeutics Holdings Inc. (ARCT) is 13.32%, while Amphastar Pharmaceuticals, Inc. (AMPH) has a volatility of 17.65%. This indicates that ARCT experiences smaller price fluctuations and is considered to be less risky than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
13.32%
17.65%
ARCT
AMPH

Financials

ARCT vs. AMPH - Financials Comparison

This section allows you to compare key financial metrics between Arcturus Therapeutics Holdings Inc. and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items